Eur Rev Med Pharmacol Sci 2023; 27 (20): 9477-9477
DOI: 10.26355/eurrev_202310_34148

Retraction Note: MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2

S.-S. Pan, H.-E. Zhou, H.-Y. Yu, L.-H. Xu

Department of Gynecology, First People’s Hospital of Fuyang District, Hangzhou, China


The article “MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2”, by S.-S. Pan, H.-E. Zhou, H.-Y. Yu, L.-H. Xu, published in Eur Rev Med Pharmacol Sci 2019; 23 (24): 10664-10671–DOI: 10.26355/eurrev_201912_19764–PMID: 31858533 has been retracted by the Authors for the following reasons:

The authors found some inaccuracies in the research due to the number of experiments, as well as problems in the editing process of pictures. These errors may mislead readers and affect scientific research in this field.

Figures 2D and 5D have also been questioned on PubPeer in April 2023.

This manuscript has been withdrawn. The Publisher apologizes for any inconvenience this may cause.

MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2

Free PDF Download

To cite this article

S.-S. Pan, H.-E. Zhou, H.-Y. Yu, L.-H. Xu
Retraction Note: MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 20
Pages: 9477-9477
DOI: 10.26355/eurrev_202310_34148